Myeloid Sarcoma as a Presentation of Acute Myeloid Leukemia and Blastic Phase in the Course of Chronic Myeloid Leukemia: A Case Report and Literature Review.
Ugo GiordanoMateusz SawickiJustyna PilchJakub MizeraArtur BorkowskiKrzysztof ZduniakJarosław DybkoPublished in: Journal of clinical medicine (2023)
The objective of this report was to emphasize the heterogeneity among the clinical manifestations of MS, to underline the relevance of the histopathological and molecular diagnostic tools in opting for the appropriate therapy, and that, in spite of it occurring rather uncommonly, physicians should think of MS in the presence of pathological masses in patients under risk of hematological malignancies.
Keyphrases
- acute myeloid leukemia
- chronic myeloid leukemia
- end stage renal disease
- mass spectrometry
- multiple sclerosis
- ms ms
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- dendritic cells
- bone marrow
- stem cells
- magnetic resonance imaging
- magnetic resonance
- mesenchymal stem cells
- computed tomography
- single molecule
- patient reported
- ultrasound guided
- replacement therapy